In a research report released Wednesday, Wedbush analyst Liana Moussatos reiterated an Outperform rating on shares of Pacira Pharmaceuticals Inc (NASDAQ:PCRX) with a price …
Shares of Pacira Pharmaceuticals Inc (NASDAQ:PCRX) took it on the chin at Thursday’s open as the company completely removed sales guidance for its only marketed …
MLV analyst Vernon Bernardino was out pounding the table on BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX), reiterating a Buy rating and price target of $15, which represents a …
